Dupilumab Under FDA Priority Review for Bullous Pemphigoid ...Middle East

Medscape - News
Dupilumab Under FDA Priority Review for Bullous Pemphigoid
Patients treated with on dupilumab showed significant improvement in sustained BP remission compared with those on placebo. Medscape Medical News

Hence then, the article about dupilumab under fda priority review for bullous pemphigoid was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Dupilumab Under FDA Priority Review for Bullous Pemphigoid )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News